← Leaderboards
Douglas J Kawahara
Elex Biotech, Llc
$2,464,445
Attributed
$2,464,445
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2019–20$2M$1.5M$1M$500K$0
'19
'20
Funding mix
By agency
NIH$2,464,445 · 2
By mechanism
R44$1,965,483 · 1
SB1$498,962 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Frequencies”
- Hanjoon Ryu$28,519,898
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Badri N Vardarajan · University Of Miami School Of Medicine$19,598,892
- Andrew S Huhn · Johns Hopkins University$13,963,436
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Boyang Wang · University Of Cincinnati Main Campus$13,261,635
Research focus
FrequenciesHeart RhythmDrug CandidateFlecainideGender DifferenceHeart ArrestArrhythmia9 Year OldEmotional StressFda ApprovedAffectBiotechnologyGenesGenetic DiseasesCardiacCatecholaminergic Polymorphic Ventricular TachycardiaCatecholaminesChildClinical Drug DevelopmentDoseEuropeEuropeanBiologyImplant
Grant awards (3)
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$966,380
R44 · FY2020 · HL · contact PI
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$498,962
SB1 · FY2020 · HL · contact PI
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$999,103
R44 · FY2019 · HL · contact PI